A Phase I Pharmacokinetic Optimal Dosing Study of Intrathecal Topotecan for Children With Neoplastic Meningitis.
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2012
At a glance
- Drugs Topotecan (Primary)
- Indications Neoplastic meningitis
- Focus Adverse reactions; Pharmacokinetics
- 13 Feb 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual patient number is 22 according to ClinicalTrials.gov.
- 13 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.